Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin plus Clarithromycin versus Ampicillin alone in early preterm premature rupture of membranes
2006-000185-37Phase 4Completed
- Sponsor
- University of Vienna
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ampicillin and clarithromycin in Preterm prelabor rupture of membranes (PPROM), bronchopulmonary dysplasia (BPD) and Ureaplasma urealyticum infection (2 arms), sponsored by University of Vienna. Primary endpoints: Neonatal bronchopulmonary dysplasia at day 28 and Neonatal chronic lung disease at 36 weeks postconceptional age. Started Aug 2006; status: completed.
02
Drugs
ampicillinclarithromycin
03
Conditions
Preterm prelabor rupture of membranes (PPROM)bronchopulmonary dysplasia (BPD)Ureaplasma urealyticum infection
Beyond the preview
Go deeper on 2006-000185-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000185-37.